Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
DMAB-anabaseine is a partial agonist of α7 nicotinic acetylcholine receptors (nAChRs).1 It induces currents in a whole-cell patch-clamp assay using Xenopus oocytes expressing human α7 nAChRs (EC50 = 21 µM). Intracerebroventricular administration of DMAB-anabaseine (80 µg/animal) inhibits nicotine-induced prostration in rats.2 It decreases prepulse inhibition deficits in sensory inhibition-deficient DBA/2J mice.3
WARNING This product is not for human or veterinary use.
1. Unique pharmacology of heteromeric α7β2 nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes. Eur. J. Pharmacol. 726, 77-86 (2014).
2. Anabaseine is a potent agonist on muscle and neuronal alpha-
3. Selective α7-